Effectiveness of Ivermectin in SARS-CoV-2/COVID-19 Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 1, 2020

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2020

Conditions
Covid19
Interventions
DRUG

Ivermectin

Ivermectin Prescribing protocol: Participants were prescribed Ivermectin 12 mg per oral stat and then 12 mg per oral after 12 hours and 12 mg per oral after 24 hours and we looked at the response at day 7 on follow up in terms of improvement of symptoms like (Fever, Cough, sore throat, Headache, Shortness of breath, lethargy, and fatigue.Any side effects of the drugs were noted as well

Trial Locations (1)

54000

Aijaz Zeeshan Khan Chachar, Lahore

All Listed Sponsors
lead

FMH College of Medicine and Dentistry

OTHER

NCT04739410 - Effectiveness of Ivermectin in SARS-CoV-2/COVID-19 Patients | Biotech Hunter | Biotech Hunter